GSTSX
Price
$10.14
Change
-$0.13 (-1.27%)
Updated
Jun 13 closing price
Net Assets
195.13M
VIGRX
Price
$215.38
Change
-$2.91 (-1.33%)
Updated
Jun 13 closing price
Net Assets
293.94B
Interact to see
Advertisement

GSTSX vs VIGRX

Header iconGSTSX vs VIGRX Comparison
Open Charts GSTSX vs VIGRXBanner chart's image
Goldman Sachs Strategic Growth Svc
Price$10.14
Change-$0.13 (-1.27%)
VolumeN/A
Net Assets195.13M
Vanguard Growth Index Investor
Price$215.38
Change-$2.91 (-1.33%)
VolumeN/A
Net Assets293.94B
GSTSX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSTSX vs. VIGRX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSTSX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 294B vs. GSTSX (195M). VIGRX pays higher dividends than GSTSX: VIGRX (0.35) vs GSTSX (0.00). GSTSX was incepted earlier than VIGRX: GSTSX (26 years) vs VIGRX (33 years). GSTSX (1.46) is less costly to investors than VIGRX (0.17). GSTSX is a more actively managed with annual turnover of: 39.00 vs. VIGRX (11.00). GSTSX has a lower initial minimum investment than VIGRX: GSTSX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 12.60 vs. GSTSX (8.68). VIGRX return over 5 years is better than : 115.22 vs. GSTSX (14.32).
GSTSXVIGRXGSTSX / VIGRX
Total Expense Ratio1.250.17735%
Annual Report Gross Expense Ratio1.460.17859%
Fund Existence26 years33 years-
Gain YTD0.9961.93651%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets195M294B0%
Annual Yield % from dividends0.000.35-
Returns for 1 year8.6812.6069%
Returns for 3 years44.2491.6448%
Returns for 5 years14.32115.2212%
Returns for 10 years-17.57286.54-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTL18.75-0.07
-0.37%
Castle Biosciences
KAVL0.53-0.01
-1.67%
Kaival Brands Innovations Group
INCY67.75-1.47
-2.12%
Incyte Corp
FLG11.04-0.36
-3.16%
Flagstar Financial Inc
TARA3.14-0.12
-3.68%
Protara Therapeutics